Gene Page:MAX
概括?
基因 | 4149 |
象征 | MAX |
Synonyms | bHLHd4 |
Description | MYC associated factor X |
Reference | MIM:154950|HGNC:HGNC:6913|Ensembl:ENSG00000125952|HPRD:01113|Vega:Otthumg00000142809 |
Gene type | protein-coding |
Map location | 14Q23 |
Pascal p-value | 0.011 |
Sherlock P值 | 0.169 |
Fetal beta | -1.249 |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
文学 | High-throughput literature-search | 与精神分裂症关键词共同存在:精神分裂症,精神分裂症,精神分裂症,精神分裂症,精神分裂症,精神分裂症 | Click to show details |
第一节遗传学和表观遗传学注释
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/MAX_DE_GTEx.png)
Gene expression during devlopment (BrainCloud)
脚注:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
大脑区域的顶级共表达基因
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
MCM2 | 0.97 | 0.86 |
TIMELESS | 0.96 | 0.86 |
CDC45L | 0.95 | 0.73 |
PCNA | 0.95 | 0.75 |
CDCA4 | 0.95 | 0.81 |
TP53 | 0.95 | 0.86 |
pold1 | 0.95 | 0.86 |
GINS2 | 0.95 | 0.76 |
FAM83D | 0.95 | 0.68 |
ORC1L | 0.94 | 0.77 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
C5orf53 | -0.51 | -0.73 |
PTH1R | -0.48 | -0.63 |
HLA-F | -0.48 | -0.62 |
FBXO2 | -0.48 | -0.59 |
AF347015.27 | -0.48 | -0.75 |
AF347015.31 | -0.47 | -0.76 |
AIFM3 | -0.47 | -0.62 |
MT-CO2 | -0.47 | -0.77 |
CA4 | -0.46 | -0.67 |
AF347015.33 | -0.46 | -0.73 |
第四节。蛋白质蛋白相互作用注释
互动者 | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
---|---|---|---|---|---|
BLOC1S1 | BLOS1 | FLJ39337 | FLJ97089 | GCN5L1 | MGC87455 | MICoA | RT14 | biogenesis of lysosomal organelles complex-1, subunit 1 | - | HPRD | 10611234 |
EP400 | CAGH32 | DKFZP434I225 | FLJ42018 | FLJ45115 | P400 | TNRC12 | E1a结合蛋白P400 | Affinity Capture-Western | BioGRID | 11509179 |
KAT2A | GCN5 | GCN5L2 | MGC102791 | PCAF-b | hGCN5 | K(lysine) acetyltransferase 2A | Affinity Capture-Western | BioGRID | 10611234 |
MAX | MGC10775 |MGC11225 |MGC18164 |MGC34679 |MGC36767 |BHLHD4 |ORF1 | MYC associated factor X | in vitro | BioGRID | 9115440|12553908 |
MAX | MGC10775 |MGC11225 |MGC18164 |MGC34679 |MGC36767 |BHLHD4 |ORF1 | MYC associated factor X | - | HPRD | 2006410|9115440|12553908 |
MNT | MAD6 | MXD6 | ROX | bHLHd3 | MAX binding protein | - | HPRD,BioGRID | 9184233 |
MSH2 | COCA1 | FCC1 | HNPCC | HNPCC1 | LCFS2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | - | HPRD,BioGRID | 12584560 |
MSH2 | COCA1 | FCC1 | HNPCC | HNPCC1 | LCFS2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | Max interacts with MSH2. This is a modeled interaction between Max from an unspecified source and human MSH2. | BIND | 12584560 |
MXD1 | MAD | MAD1 | MGC104659 | 最大二聚化蛋白1 | in vitro in vivo Reconstituted Complex 两个杂交 |
BioGRID | 8425218|9528857 |10229200|11602341 |12391307 |
MXD1 | MAD | MAD1 | MGC104659 | 最大二聚化蛋白1 | Max与MAD1互动。 | BIND | 9528857 |
MXD1 | MAD | MAD1 | MGC104659 | 最大二聚化蛋白1 | - | HPRD | 8425218|10229200 |11602341 | 10229200|11602341 |
MXD3 | MAD3 | MGC2383 | bHLHc13 | 最大二聚化蛋白3 | 两个杂交 | BioGRID | 9528857|10593926 |
MXD3 | MAD3 | MGC2383 | bHLHc13 | 最大二聚化蛋白3 | - | HPRD | 8521822 |
MXD4 | MAD4 | MST149 | MSTP149 | bHLHc12 | 最大二聚化蛋白4 | 两个杂交 | BioGRID | 9528857|10593926 |
MXD4 | MAD4 | MST149 | MSTP149 | bHLHc12 | 最大二聚化蛋白4 | - | HPRD | 8521822 |
MXI1 | MAD2 | MGC43220 | MXD2 | MXI | bHLHc11 | MAX interactor 1 | 两个杂交 | BioGRID | 9528857|10593926 |16189514 |
MXI1 | MAD2 | MGC43220 | MXD2 | MXI | bHLHc11 | MAX interactor 1 | Max interacts with Mxi1. | BIND | 9528857 |
MYC | bHLHe39 | c-Myc | v-myc myelocytomatosis viral oncogene homolog (avian) | Myc interacts with Max. This interaction was modeled on a demonstrated interaction between human Myc and Max from an unspecified source. | BIND | 12584560 |
MYC | bHLHe39 | c-Myc | v-myc myelocytomatosis viral oncogene homolog (avian) | 亲和力捕获ms Affinity Capture-Western in vitro in vivo Reconstituted Complex 两个杂交 |
BioGRID | 2006410|9528857 |9708738|10229200 |10319872|10593926 |10611234|12391307 |12584560|17353931 |
MYC | bHLHe39 | c-Myc | v-myc myelocytomatosis viral oncogene homolog (avian) | - | HPRD | 2006410|10229200 |
mycl1 | lmyc |mycl |Bhlhe38 | v-myc myelocytomatosis病毒致癌基因同族体1,lung carcinoma derived (avian) | - | HPRD,BioGRID | 10229200 |
mycl2 | - | v-myc myelocytomatosis viral oncogene homolog 2 (avian) | in vitro | BioGRID | 10229200 |
MYCN | 模拟|n-myc |NMYC |ODED |Bhlhe37 | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | - | HPRD,BioGRID | 10229200 |
plekhf2 | FLJ13187 | PHAFIN2 | ZFYVE18 | pleckstrin homology domain containing, family F (with FYVE domain) member 2 | 两个杂交 | BioGRID | 16189514 |
SMAD3 | DKFZp586N0721 | DKFZp686J10186 | HSPC193 | HsT17436 | JV15-2 | MADH3 | MGC60396 | SMAD family member 3 | - | HPRD,BioGRID | 12551947 |
SMAD4 | DPC4 | JIP | MADH4 | SMAD family member 4 | - | HPRD,BioGRID | 12551947 |
意大利面9 | FLJ13450 | FLJ14006 | FLJ26141 | FLJ34602 | HLC4 | JLP | KIAA0516 | MGC117291 | MGC14967 | MGC74461 | PHET | PIG6 | sperm associated antigen 9 | - | HPRD,BioGRID | 12391307 |
TEAD1 | AA | REF1 | TCF13 | TEF-1 | 茶域家庭成员1(SV40转录增强因子) | - | HPRD,BioGRID | 9199327 |
TRRAP | FLJ10671 | PAF350/400 | PAF400 | STAF40 | TR-AP | Tra1 | 转化/转录结构域相关蛋白 | - | HPRD,BioGRID | 10611234 |
ZBTB17 | MIZ-1 | ZNF151 | ZNF60 | pHZ-67 | 锌指和包含17的BTB结构域 | Reconstituted Complex | BioGRID | 11283613 |
V.途径注释
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG MAPK SIGNALING PATHWAY | 267 | 205 | 该途径中的所有SZGR 2.0基因 |
KEGG PATHWAYS IN CANCER | 328 | 259 | 该途径中的所有SZGR 2.0基因 |
KEGG SMALL CELL LUNG CANCER | 84 | 67 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA MAPK PATHWAY | 87 | 68 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA P38MAPK PATHWAY | 40 | 31 | 该途径中的所有SZGR 2.0基因 |
PID SMAD2 3NUCLEAR PATHWAY | 82 | 63 | 该途径中的所有SZGR 2.0基因 |
PID MYC ACTIV PATHWAY | 79 | 62 | 该途径中的所有SZGR 2.0基因 |
PID HDAC CLASSI PATHWAY | 66 | 50 | 该途径中的所有SZGR 2.0基因 |
PID TELOMERASE PATHWAY | 68 | 48 | 该途径中的所有SZGR 2.0基因 |
PID MYC PATHWAY | 25 | 22 | 该途径中的所有SZGR 2.0基因 |
pid myc抑制道路 | 63 | 52 | 该途径中的所有SZGR 2.0基因 |
REACTOME CELL CYCLE | 421 | 253 | 该途径中的所有SZGR 2.0基因 |
REACTOME CELL CYCLE MITOTIC | 325 | 185 | 该途径中的所有SZGR 2.0基因 |
REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | 65 | 40 | 该途径中的所有SZGR 2.0基因 |
REACTOME G1 S TRANSITION | 112 | 63 | 该途径中的所有SZGR 2.0基因 |
REACTOME MITOTIC G1 G1 S PHASES | 137 | 79 | 该途径中的所有SZGR 2.0基因 |
REACTOME S PHASE | 109 | 66 | 该途径中的所有SZGR 2.0基因 |
GAZDA DIAMOND BLACKFAN ANEMIA ERYTHROID DN | 493 | 298 | 该途径中的所有SZGR 2.0基因 |
Fulcher炎症反应凝集素与LPS DN | 463 | 290 | 该途径中的所有SZGR 2.0基因 |
GARY CD5 TARGETS DN | 431 | 263 | 该途径中的所有SZGR 2.0基因 |
THUM SYSTOLIC HEART FAILURE UP | 423 | 283 | 该途径中的所有SZGR 2.0基因 |
WANG LMO4 TARGETS UP | 372 | 227 | 该途径中的所有SZGR 2.0基因 |
RHEIN ALL GLUCOCORTICOID THERAPY UP | 78 | 41 | 该途径中的所有SZGR 2.0基因 |
SENESE HDAC1 TARGETS UP | 457 | 269 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN APOPTOSIS BY SERUM DEPRIVATION UP | 552 | 347 | 该途径中的所有SZGR 2.0基因 |
VANHARANTA UTERINE FIBROID WITH 7Q DELETION UP | 67 | 37 | 该途径中的所有SZGR 2.0基因 |
RIZ ERYTHROID DIFFERENTIATION | 77 | 51 | 该途径中的所有SZGR 2.0基因 |
TSAI对电离辐射的响应 | 149 | 101 | 该途径中的所有SZGR 2.0基因 |
PUJANA BRCA1 PCC NETWORK | 1652 | 1023 | 该途径中的所有SZGR 2.0基因 |
Pujana ATM PCC网络 | 1442 | 892 | 该途径中的所有SZGR 2.0基因 |
NUYTTEN EZH2 TARGETS UP | 1037 | 673 | 该途径中的所有SZGR 2.0基因 |
洛佩兹MBD目标 | 957 | 597 | 该途径中的所有SZGR 2.0基因 |
Shin B细胞淋巴瘤簇7 | 27 | 22 | 该途径中的所有SZGR 2.0基因 |
Onder CDH1目标1 DN | 169 | 102 | 该途径中的所有SZGR 2.0基因 |
Yagi AML Fab标记 | 191 | 131 | 该途径中的所有SZGR 2.0基因 |
BROWNE HCMV INFECTION 8HR UP | 105 | 73 | 该途径中的所有SZGR 2.0基因 |
BLALOCK ALZHEIMERS DISEASE UP | 1691年 | 1088 | 该途径中的所有SZGR 2.0基因 |
BROWNE HCMV INFECTION 14HR UP | 156 | 101 | 该途径中的所有SZGR 2.0基因 |
伽玛辐射8G后的生存率不佳 | 95 | 62 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ RB1 TARGETS DN | 543 | 317 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ TP53 TARGETS DN | 593 | 372 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ RB1 AND TP53 TARGETS DN | 591 | 366 | 该途径中的所有SZGR 2.0基因 |
Chung水泡细胞毒性DN | 44 | 29 | 该途径中的所有SZGR 2.0基因 |
Yoshimura MAPK8目标DN | 366 | 257 | 该途径中的所有SZGR 2.0基因 |
RAGHAVACHARI PLATELET SPECIFIC GENES | 70 | 46 | 该途径中的所有SZGR 2.0基因 |
PANGAS TUMOR SUPPRESSION BY SMAD1 AND SMAD5 DN | 157 | 106 | 该途径中的所有SZGR 2.0基因 |
DELPUECH FOXO3 TARGETS UP | 68 | 49 | 该途径中的所有SZGR 2.0基因 |
RAO BOUND BY SALL4 | 227 | 149 | 该途径中的所有SZGR 2.0基因 |